Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-20 4:16 pm Purchase | 2022-12-31 | 13G | PROJECT ENERGY REIMAGINED ACQ. PEGR | Integrated Core Strategies (US) LLC | 1,716,723 6.500% | 291,542![]() (+20.46%) | Filing History |
| 2023-01-20 4:13 pm Purchase | 2023-01-11 | 13G | ESPERION THERAPEUTICS INC ESPR | Integrated Core Strategies (US) LLC | 3,623,902 4.900% | 3,623,902![]() (New Position) | Filing History |
| 2023-01-20 4:09 pm Purchase | 2023-01-13 | 13G | ORIC PHARMACEUTICALS INC ORIC | Integrated Core Strategies (US) LLC | 2,433,850 5.400% | 2,433,850![]() (New Position) | Filing History |
| 2023-01-19 4:25 pm Sale | 2022-12-31 | 13G | PHILLIPS EDISON & CO INC N PECO | Integrated Core Strategies (US) LLC | 721,599 0.600% | -6,599,609![]() (-90.14%) | Filing History |
| 2023-01-19 4:19 pm Purchase | 2022-12-31 | 13G | PUMA BIOTECHNOLOGY INC PBYI | Integrated Core Strategies (US) LLC | 2,676,913 5.800% | 439,214![]() (+19.63%) | Filing History |
| 2023-01-19 4:14 pm Sale | 2022-12-31 | 13G | NETSTREIT CORP NTST | Integrated Core Strategies (US) LLC | 1,991,348 3.600% | -1,184,275![]() (-37.29%) | Filing History |
| 2023-01-19 4:10 pm Sale | 2022-12-31 | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Integrated Core Strategies (US) LLC | 79,363 3.700% | -27,266![]() (-25.57%) | Filing History |
| 2023-01-19 4:06 pm Sale | 2022-12-31 | 13G | MERSANA THERAPEUTICS INC MRSN | Integrated Core Strategies (US) LLC | 146,541 3.700% | -2,687![]() (-1.80%) | Filing History |
| 2023-01-18 4:34 pm Sale | 2022-12-31 | 13G | ROSE HILL ACQUISITION CORP ROSE | Integrated Core Strategies (US) LLC | 237,500 1.700% | -575,000![]() (-70.77%) | Filing History |
| 2023-01-18 4:30 pm Sale | 2022-12-31 | 13G | PERCEPTION CAP CORP II PCCT | Integrated Core Strategies (US) LLC | 0 0.000% | -1,363,765![]() (Position Closed) | Filing History |
| 2023-01-18 4:24 pm Purchase | 2022-12-31 | 13G | MASON INDL TECHNOLOGY INC MIT | Integrated Core Strategies (US) LLC | 2,581,505 5.200% | 913![]() (+0.04%) | Filing History |
| 2023-01-18 4:20 pm Sale | 2022-12-31 | 13G | MACROGENICS INC MGNX | Integrated Core Strategies (US) LLC | 2,807,235 4.600% | -380,404![]() (-11.93%) | Filing History |
| 2023-01-17 4:28 pm Sale | 2022-12-31 | 13G | MINORITY EQUALITY OPPORTUNITIE MEOA | Integrated Core Strategies (US) LLC | 0 0.000% | -647,941![]() (Position Closed) | Filing History |
| 2023-01-17 4:23 pm Sale | 2022-12-31 | 13G | M3-BRIGADE ACQ. II CORP C MBAC | Integrated Core Strategies (US) LLC | 1,521,053 3.800% | -564,186![]() (-27.06%) | Filing History |
| 2023-01-17 4:19 pm Sale | 2022-12-31 | 13G | LIBERTY TRIPADVISOR HLDGS INC LTRPA | Integrated Core Strategies (US) LLC | 2,851,073 3.900% | -978,494![]() (-25.55%) | Filing History |
| 2023-01-17 4:15 pm Sale | 2022-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | Integrated Core Strategies (US) LLC | 289,650 4.200% | -13,013![]() (-4.30%) | Filing History |
| 2023-01-17 4:11 pm Sale | 2022-12-31 | 13G | KINS TECHNOLOGY GROUP INC KINZ | Integrated Core Strategies (US) LLC | 0 0.000% | -1,427,397![]() (Position Closed) | Filing History |
| 2023-01-17 4:06 pm Sale | 2022-12-31 | 13G | IX ACQUISITION CORP IXAQF | Integrated Core Strategies (US) LLC | 1,168,212 5.100% | -1,788![]() (-0.15%) | Filing History |
| 2023-01-13 4:20 pm Sale | 2022-12-31 | 13G | INDEPENDENCE RLTY TR INC IRT | Integrated Core Strategies (US) LLC | 467 0.000% | -13,664,097![]() (-100.00%) | Filing History |
| 2023-01-13 4:17 pm Sale | 2022-12-31 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | Integrated Core Strategies (US) LLC | 976,706 2.400% | -547,610![]() (-35.92%) | Filing History |

